| Ytd | -31.77% | |
| 1y | -59.68% |
| Open | 3.50 | Prev Close | 3.52 | Low | 3.50 | High | 3.50 | Mkt Cap | 1.19B |
| Vol | 2.98K | Avg Vol | 712.35K | EPS | -0.34 | P/E | -10.35 | Forward P/E | 13.97 |
| Beta | 0.19 | Short Ratio | 2.46 | Inst. Own | 5.17% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-06 | 50-d Avg | 3.56 | 200-d Avg | 4.67 | 1yr Est | 14.60 |
ALVO News
Attached are copies of two filings with the Luxembourg Commission de Surveillance du Secteur Financi
— $75 million additional term loan facility maturing December 31, 2027, led by GoldenTree Asset Mana
REYKJAVIK, ICELAND (July 1, 2026) — Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology compan
Attached is a copy of a filing with the Luxembourg Commission de Surveillance du Secteur Financier (
REYKJAVIK, Iceland, June 18, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech”
REYKJAVIK, ICELAND (June 18, 2026) — Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”
US stock futures up 0.1%, Dave and Buster's (PLAY) down 13.4% pre-market due to lower earnings;
HITI rose sharply in pre-market trading on strong Q2 results and continued to rise after market open
REYKJAVIK, ICELAND (June 16, 2026) — Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”
REYKJAVIK, Iceland, June 15, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech”
Attached is a copy of a filing with the Luxembourg Commission de Surveillance du Secteur Financier (
Alvotech (ALVO) Presents at UBS Virtual Generics and Biosimilars Day Transcript
Alvotech NASDAQ: ALVO Chief Strategy Officer Balaji Prasad said the biosimilars-focused company is e
Alvotech (ALVO) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Alvotech remains a commercial-stage biosimilar company with real revenue, partners, and a growing gl
REYKJAVIK, Iceland, June 08, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB), a global bi
Alvotech shares surge after the company resubmits FDA applications for its biosimilar candidates, AV
Alvotech NASDAQ: ALVO is at an “inflection point” after more than a decade of investment in its bios
REYKJAVIK, Iceland, June 04, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB), a global bi
The 2026 Annual and Extraordinary General Meeting of Alvotech (the "2026 AGM") was held on June 3, 2
REYKJAVIK, Iceland, June 02, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (the “Compan
REYKJAVIK, ICELAND (June 1, 2026) — Alvotech (Nasdaq: ALVO) and Islandsbanki have renewed and amend
Alvotech (ALVO) Presents at Bank of America Global Healthcare Conference 2026 Transcript
U.S. stock futures down, Nasdaq 100 falls over 100 points. Mach Natural Resources LP (MNR) shares di
Shares of nCino Inc (NASDAQ: NCNO) jumped 18% in pre-market trading after reporting strong Q4 result
Companies Reporting Before The Bell • Lightspeed Commerce (NYSE:LSPD) is projected to report quarte
On Thursday, 588 stocks hit new 52-week lows.
On Friday, 61 companies hit new 52-week lows.